Analytical Data
-
Gene name
A30L
- Application
-
Alternative Names
(Protein A30)
-
Species
Monkeypox virus
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8V4U9
-
Expression Region
22-146aa
-
Molecular Weight
18.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The A30L protein, a vital component of the African swine fever virus (ASFV), has garnered significant attention in virology and immunology research due to its potential role in viral pathogenesis and immune evasion strategies. ASFV, a highly contagious and lethal pathogen affecting domestic and wild pigs, poses a critical threat to global swine production and food security. A30L is known to modulate host immune responses, particularly by inhibiting the interferon signaling pathway, which is a key component of the host's antiviral defense. Understanding the structure and function of A30L is crucial for elucidating its mechanisms in immune evasion and developing effective vaccines or therapeutic strategies. Recent advances in recombinant protein technology have enabled the production of A30L for detailed biochemical and structural studies, allowing researchers to assess its interactions with host proteins and its effects on cellular signaling pathways. The insights gained from these studies may pave the way for novel approaches to combat ASFV and improve the resilience of swine populations against this devastating disease. As the global incidence of ASF continues to rise, research on A30L not only contributes to basic virology but also has practical implications for controlling outbreaks and protecting livestock industries worldwide.
